Type 2 DM

 Control Group

Comorbid chronic disease
mean±SD

No additional disease
mean±SD

p

Comorbid chronic
diseasemean±SD

No additional disease
mean±SD

p

HAD-A

7.77±5.03

5.15±3.60

0.006

7.68±4.143

5.91±4.02

0.034

HAD-D

8.08±4.92

5.19±4.03

0.008

6.05±3.40

4.95±3.17

0.103

Physica functioning

55.95±28.96

77.11±23.25

<0.001

73.33±23.23

82.56±18.50

0.145

Physical role

34.46±41.73

49.04±42.71

0.049

75.00±36.29

86.05±25.77

0.090

Pain

58.26±66.73

70.35±24.93

0.007

67.44±19.82

66.80±19.83

0.035

General health

41.23±27.33

53.31±24.51

0.050

57.56±17.13

65.80±17.73

0.872

Energy

46.15±28.56

64.04±25.18

0.006

59.91±16.84

65.00±15.58

0.021

Social functioning

59.12±34.08

79.33±26.44

0.007

76.32±19.29

78.49±15.51

0.126

Emotional role

36.04±39.31

47.44±42.35

0.246

67.25±41.54

80.62±33.52

0.546

Mental health

54.64±21.97

66.92±15.74

0.003

65.96±15.86

68.28±10.92

0.390

Table 4: Comparisons of HAD and SF-36 mean scores in the patient and control groups in terms of presence or absence of co-morbid disease.